SCHEMBL28208995

SCHEMBL28208995

CCCC(C(=O)O)c1ccccc1C(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.44
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
ABCB1 P08183 2/20 0.42
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
ALDH1A1 P00352 4/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 2/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10941204 0.88 ALDH1A1 (0.45) AKR1C3ABCB1ALDH1A1LMNA
SCHEMBL10941152 0.88 ALDH1A1 (0.45) AKR1C3ABCB1ALDH1A1LMNA
SCHEMBL10941421 0.88 ALDH1A1 (0.45) AKR1C3ABCB1ALDH1A1LMNA
SCHEMBL28209564 0.87 AKR1C3 (0.47) AKR1C3GAAMAPTABCB1BCL2
SCHEMBL10579959 0.84 AKR1C3 (0.47) AKR1C3GAAMAPTABCB1BCL2
SCHEMBL5322911 0.83 MAPT (0.41) MAPTALDH1A1SLC6A3KMT2AMEN1
SCHEMBL8013779 0.79 AKR1C3 (0.42) AKR1C3GAAMAPTABCB1BCL2
SCHEMBL9294586 0.79 CYSLTR2 (0.46) AKR1C3GAAMAPTABCB1BCL2
SCHEMBL297996 0.79 PPARG (0.39) ALDH1A1SLC6A2SLC6A3KMT2AMEN1
SCHEMBL28408034 0.78 AKR1C3 (0.52) AKR1C3GAAMAPTABCB1BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104284891-B Conformationally constrained, fully synthetic macrocyclic compounds 波利弗尔股份公司 2018-04-17 CN disclosed